Related content

The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability

By Duke D.   Moran L.   Pearce R.   Graeber M.  

Neurogenetics, Vol. 8, Iss. 2, 2007-04 ,pp. : 83-94

Springer Publishing Company

Access to resources Recommend Favorite

Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson’s disease

By Zhou Bing   Yuan Fangzhen   He Zhong   Tan Changlian  

Brain Imaging and Behavior, Vol. 8, Iss. 1, 2014-03 ,pp. : 97-101

Springer Publishing Company

Access to resources Recommend Favorite

Screening for mutations of the IRP2 gene in Parkinson’s disease patients with hyperechogenicity of the substantia nigra

By Deplazes J.   Schöbel K.   Hochstrasser H.   Bauer P.   Walter U.   Behnke S.   Spiegel J.   Becker G.   Riess O.   Berg D.  

Journal of Neural Transmission, Vol. 111, Iss. 4, 2004-04 ,pp. : 515-521

Springer Publishing Company

Access to resources Recommend Favorite

An Altered Histaminergic Innervation of the Substantia Nigra in Parkinson's Disease

By Anichtchik O.V.   Rinne J.O.   Kalimo H.   Panula P.  

Experimental Neurology, Vol. 163, Iss. 1, 2000-05 ,pp. : 20-30

Elsevier

Access to resources Recommend Favorite

Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity

By Schweitzer K. J.   Behnke S.   Liepelt I.   Wolf B.   Grosser C.   Godau J.   Gaenslen A.   Bruessel T.   Wendt A.   Abel F.   Müller A.   Gasser T.   Berg D.  

Journal of Neural Transmission, Vol. 114, Iss. 9, 2007-09 ,pp. : 1167-1171

Springer Publishing Company

Access to resources Recommend Favorite